Search Results - "Watson, Thelma M"

Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen by NEELAPU, Sattva S, BASKAR, Sivasubramanian, POPESCU, Mircea C, KWAK, Larry W, GAUSE, Barry L, KOBRIN, Carol B, WATSON, Thelma M, FRYE, Andrea Robin, PENNINGTON, Robin, HARVEY, Linda, JAFFE, Elaine S, ROBB, Richard J

“…Purpose: The idiotype (Id) of the immunoglobulin on a given B-cell malignancy is a clonal marker that can serve as a tumor-specific antigen. We developed a…”
Get full text

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma by Kwak, Larry W, Bendandi, Maurizio, Gocke, Christopher D, Kobrin, Carol B, Benko, Floyd A, Sternas, Lars A, Pennington, Robin, Watson, Thelma M, Reynolds, Craig W, Gause, Barry L, Duffey, Patricia L, Jaffe, Elaine S, Creekmore, Stephen P, Longo, Dan L

“…Lymphomas express a tumor-specific antigen which can be targeted by cancer vaccination. We evaluated the ability of a new idiotype protein vaccine formulation…”
Get full text

Phase III Randomized Trial of Patient-Specific Vaccination for Previously Untreated Patients with Follicular Lymphoma in First Complete Remission: Protocol Summary and Interim Report by Neelapu, Sattva S., Gause, Barry L., Nikcevich, Daniel A., Schuster, Stephen J., Winter, Jane, Gockerman, Jon P., Loughran, Thomas, Takeshita, Ken, Inghirami, Giorgio, McGaughey, Dean, Watson, Thelma M., Snow, Sandra, Kubovic, Paula, Ferraro, Miriam, Jones, Elizabeth, Jaffe, Elaine S., Schwartzentruber, Douglas J., Danforth, David, Sherry, Richard, Kass, Erik, Van Waes, Carter, Reynolds, Craig W., Kwak, Larry W.

Get full text

Tumor Antigen Immunization of Sibling Stem Cell Transplant Donors in Multiple Myeloma by Neelapu, Sattva S., Munshi, Nikhil C., Jagannath, Sundar, Watson, Thelma M., Pennington, Robin, Barlogie, Bart, Kwak, Larry W.

“…Strategies to enhance the specific anti-tumor effect of the graft without increasing the risk of graft-versus-host disease (GVHD) are needed to improve the…”
Get full text

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin by Miller, Langdon L., Korn, Edward L., Stevens, Diane S., Janik, John E., Gause, Barry L., Kopp, William C., Holmlund, Jon T., Curti, Brendan D., Sznol, Mario, Smith, John W., Urba, Walter J., Donegan, Sarah E., Watson, Thelma M., Longo, Dan L.

“…This dose-escalation study was performed to evaluate the hematologic activity, biological effects, immunogenicity, and toxicity of PIXY321 (an…”
Get full text